Welcome to the website of Tianjin ouerke Pharmaceutical Technology Co., Ltd !
Tianjin Ouerke Pharmaceutical Technology Co., Ltd
HotLine:

+86-18519864321

HOT KEYWORDS:ELISAACRIDINETRFIA

PRODUCTS

CONTACT US

Tianjin Ouerke Pharmaceutical Technology Co., Ltd

Contacts:Mr.Chi
Email:ethan@kangeryl.com
Mobile:+86-18519864321
Address:guotai road ,dajiangcheng town,wuqing district,tianjin,china

Your location:Home >> PRODUCTS >> ACRIDINE

ACRIDINE

Time:2022-09-13Click:81

Six Items of Thrombosis

Project introduction

The six thrombus indicators are effective indicators that can effectively reflect the early changes of the collective vascular endothelium, coagulation and fibrinolysis system, and are applicable to the early diagnosis and risk assessment of high-risk groups of thrombus in various clinical departments.

Clinical application

TAT

Reflect the thrombin content, predict the early formation and degree of thrombus, and evaluate the activation status of the coagulation system; assist in diagnosis of DIC, monitor thrombolytic effect and thrombus recurrence.

 

PIC

Reflect the fibrinolytic enzyme content and the fibrinolytic activation status several hours before blood collection; Auxiliary diagnosis of DIC or pre-DIC and other thrombotic diseases, and detection of thrombolytic effect.

 

TM

Vascular endothelial cells synthesize and combine with thrombin to reduce the coagulation activity of thrombin, and activate protein C with anticoagulant effect, thereby inhibiting thrombosis;

Auxiliary diagnosis DIC, atherosclerosis.

 

t-PAIC

Comprehensively reflect the state of endothelial system and fibrinolytic system;

Assist in diagnosing venous thrombosis and myocardial infarction, judge the repair degree of vascular endothelial system after operation, and monitor the thrombolytic effect.

 

FDP

Reflect the fibrinolytic function of fibrinolytic protein and screen the fibrinolytic system activity;

Assist in the diagnosis of primary and secondary fibrinolysis related diseases, tumors, pregnancy induced hypertension, liver diseases, and monitor the progress of thrombotic diseases.

 

D-Dimer

One of fibrin degradation products, which is a unique metabolite of secondary fibrinolysis, the final result of coagulation disorder, and a marker of late thrombosis;

Assist in the diagnosis of secondary fibrinolysis related diseases, identify primary and secondary fibrinolysis, and monitor the thrombolytic treatment effect and thrombus recurrence.


Call-center
Hotline

Hotline

+86-18519864321

WeChat
Tianjin Ouerke Pharmaceutical Technology Co., Ltd
TOP